DATA: 14/01/2019
Il nostro IX Congresso Nazionale è stato un successo!
Oltre 500 clinici esperti nelle IBD si sono confrontati su diagnosi, terapia e modelli gestionali.
Oltre 500 clinici esperti nelle IBD si sono confrontati su diagnosi, terapia e modelli gestionali.
29 Novembre 2018
17:30 | M. C. Fantini: The gastroenterologis perspectives |
30 Novembre 2018
09:00 | A. Rispo: EARLY TREATMENT: IS THERE A WINDOW OF OPPORTUNITY IN IBD? |
09:20 | G. Fiorino: Treat to target in IBD: why the uptake is still a challenge? |
09:40 | D. Pugliese: Drug withdrawal IBD: few evidence, lots of strategies |
11:30 | P. Gionchetti: Biologic Therapy in IBD: Old, New and What Clinicians Should Know |
11:50 | F. Caprioli: Small molecules and new therapeutic targets |
12:30 | D. García-Olmo: Stem Cells in Perianal Crohn’s Disease |
16:00 | V. Villanacci: Histologic Scoring Indices In Ulcerative Colitis: A Critical Reappraisal |
1 Dicembre 2018
09:00 | F. Rizzello: Optimal timing for surgery: a multidisciplinary approach!!! Gastroenterological point of view G. Poggioli: Optimal timing for surgery: a multidisciplinary approach? Surgical point of view |
09:30 | S. Scaringi: Preoperative management in IBD |
09:50 | I. Angriman: Enhanced recovery after surgery |
15:10 | F. Castiglione: Minimising risks during pregnancy |
15:30 | M. L. Scribano: The management of IBD patients with cancer history |